Kidney disease in Africans with HIV and tuberculosis

OBJECTIVE:To describe the spectrum of kidney disease in African patients with HIV and tuberculosis (TB). METHODS:We used data from three cohortsconsecutive patients with HIV/TB in South London (UK, 2004–2016; n = 95), consecutive patients with HIV/TB who underwent kidney biopsy in Cape Town (South Africa, 2014–2017; n = 70), and consecutive patients found to have HIV/TB on autopsy in Abidjan (Cote d’Ivoire, 1991; n = 100). Acute kidney injury (AKI) was ascertained using the Kidney DiseaseImproving Global Outcomes (KDIGO) criteria. In the Cape Town cohort, predictors of recovery of kidney function at 6 months were assessed using Cox regression. RESULTS:In the London cohort, the incidence of moderate/severe AKI at 12 months was 15.1 (95% CI 8.6–26.5) per 100 person-years, and the prevalence of chronic and end-stage kidney disease (ESKD) 13.7 and 5.7%, respectively. HIV-associated nephropathy (HIVAN) was diagnosed in 6% of patients in London, and in 6% of autopsy cases in Abidjan. Evidence of renal TB was present in 60% of autopsies in Abidjan and 61% of kidney biopsies in Cape Town. HIVAN and acute tubular necrosis (ATN) were also common biopsy findings in Cape Town. In Cape Town, 40 patients were dialyzed, of whom 28 (70%) were able to successfully discontinue renal replacement therapy. Antiretroviral therapy status, CD4 cell count, estimated glomerular filtration rate (eGFR) at biopsy and renal histology, other than ATN, were not predictive of eGFR recovery. CONCLUSION:Kidney disease was common in Africans with HIV/TB. Monitoring of kidney function, and provision of acute dialysis to those with severe kidney failure, is warranted.